Glioblastoma multiforme is the most common and lethal primary brain cancer in adults. Tumor cells diffusely infiltrate the brain making focal surgical and radiation treatment challenging. The invasion of glioma cells into normal brain is facilitated by the activity of ion channels aiding dynamic regulation of cell volume. Recent studies have specifically implicated ClC-3, a voltage-gated chloride channel, in this process. However, the interaction between ClC-3 activity and cell movement is poorly understood. Here, we demonstrate that ClC-3 is highly expressed on the plasma membrane of human glioma cells where its activity is regulated through phosphorylation via Ca 2؉ /calmodulin-dependent protein kinase II (CaMKII). Intracellular infusion of autoactivated CaMKII via patch pipette enhanced chloride currents 3-fold, and this regulation was inhibited by autocamtide-2 related inhibitory peptide, a CaMKII-specific inhibitor. CaMKII modulation of chloride currents was also lost upon stable small hairpin RNA knockdown of ClC-3 channels indicating a specific interaction of ClC-3 and CaMKII. In ClC-3-expressing cells, inhibition of CaMKII reduced glioma invasion to the same extent as direct inhibition of ClC-3. The importance of the molecular interaction of ClC-3 and CaMKII is further supported by our finding that CaMKII co-localizes and co-immunoprecipitates with ClC-3. ClC-3 and CaMKII also co-immunoprecipitate in tissue biopsies from patients diagnosed with grade IV glioblastoma. These tumor samples show 10-fold higher ClC-3 protein expression than nonmalignant brain. These data suggest that CaMKII is a molecular link translating intracellular calcium changes, which are intrinsically associated with glioma migration, to changes in ClC-3 conductance required for cell movement.Glioblastomas account for 60 -70% of malignant gliomas (1) and are the most common and lethal type of primary malignant brain tumors among adults. The prognosis for glioblastoma patients is poor despite treatment consisting of surgical debulking, radiotherapy, and chemotherapy. A unique feature contributing to the disease aggressiveness is the ability of malignant glioma cells to actively migrate along the brain vasculature (2, 3) instead of passive metastasis through vascular circulation. To migrate along blood vessels through the narrow extracellular space of the brain, cells must be able to regulate their cell volume. We hypothesize that gliomas express ion channels that endow cells with an enhanced ability to extrude osmotically active ions, leading to the release of cytoplasmic water and cell shrinkage (4). Candidate channels providing the electrochemical driving force for ion movement in glioma cells are the Ca 2ϩ -activated potassium channel BK (5-7) and the voltage-gated chloride channel ClC-3 (8 -10).ClC-3 enhances migration of nasopharyngeal carcinoma cells (11), and pharmacological inhibition with NPPB 2 demonstrates a requirement for chloride channels to support glioma invasion (8). Glioma cells express three members of the ClC family...